Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
Hydrogels are biocompatible drug delivery systems by which the physical properties can be controlled by the cross-linking density. Hydrogels were prepared by copolymerization of acrylic acid monomers in the presence of poly(ethylene glycol)(PEG) to form polyethylene diacrylate (PEDGA). Various molecular weights of PEGs were used for the synthesis of PEGDA to study the effect of molecular weight of PEG on the properties of hydrogels. These hydrogels were further characterized for free water, swelling..


Pharmaceutical Technology


Conclusion

Generally, in case of cross-linking agents such as divinyl glycol, divinyl benzene, or tripropyleneglycol diacrylate, an increase in cross-linking density is known to reduce the equilibrium swelling (35, 36). In this study, where polyethylene diacrylate (PEDGA) was used as cross-linker, an increase in equilibrium swelling was observed with the increase in the amount of PEGDA. This change may be from PEGDA as it is a water-retaining compound. Because it is serving as a copolymer in the present hydrogel system, the properties of PEGDA affects the properties of these copolymeric hydrogels. The diffusion coefficient and drug-release rate, however, followed the general trend: An increase in the amount of PEGDA reduced the diffusion coefficient and release rate because of an increase in cross-linking density. Apart from the cross-linking density, in this study the larger amounts of cross-linker PEGDA, having somewhat higher affinity for water, made the diffusion a little more difficult. In all the experiments, for the similar weight composition, the increase in molecular weight of PEG led to a decrease in the water-imbibing capacity and drug-loading capacity of the hydrogels because of the reduction in hydrophilicity of the system.

The diffusion coefficient and drug-release rate, however, increased with the increase in molecular weight. These results also were related to the porosity of the hydrogels. The porosity of the hydrogels decreased with an increase of the amount of PEGDA and increased with an increase in molecular weight. This change may be from a significant reduction in molecular availability of poly(ethylene glycol) cross-linkers in the polyacrylate hydrogel matrix. The chemical representation of the hydrogels made up of different molecular weight PEGDA (see Figure 4) also supported this assumption of the porosity of hydrogels.

Acknowledgment

The authors acknowledge the University Grants Commission (New Delhi, India) and the Council of Scientific and Industrial Research (New Delhi, India) for funding the research projects as fellowship grants to some of the authors. The authors extend their deep gratitude to Electron Microscopy Division of All India Institute of Medical Sciences (New Delhi, India), Sun Pharmaceuticals (Baroda, India) and SAIF-RSIC, Central Drug Research Institute (CDRI) (Lucknow, India) for extending their instrumentation facilities for the purpose of the sample analysis.

Sulekha Bhadra,PhD, and Dipankar Bhadra, PhD, are research officers in Sun Pharma's Advanced Research Center, Vadodara, India. Govind Prasad Agrawal* is a professor, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, Madhya Pradesh, India, 470003, tel. + 91 7582 265457,

*To whom all correspondence should be addressed.

Submitted: Feb. 20, 2006. Accepted: Aug. 28, 2006.

Key words: acrylate, copolymer, diclofenac, hydrogels, PEG

References

1. N.A. Peppas and A.G. Mikos, "Preparation Methods and Structure of Hydrogels," in Hydrogels in Medicine and Pharmacy, N.A. Peppas, Ed. (CRC Press, Boca Raton, FL, Vol. 1, 1986), pp. 1–27.

2. L.B. Peppas, "Preparation and Characterization of Crosslinked Hydrophilic Networks," in Absorbent Polymer Technology, L.B. Peppas and R.S. Harland, Eds. (Elsevier, Amsterdam, 1990), pp. 45–66.

3. A.S. Hickey and N.A. Peppas, "Mesh Size and Diffusive Characteristics of Semicrystalline Polyvinyl Alcohol Membranes Preparation by Freezing/Thawing Technology," J. Membrane Sc. 107 (3), 229–237 (1995).

4. N.A. Peppas and N.K. Mongia, "Ultrapure Polyvinyl Alcohol Hydrogels with Mucoadhesive Drug Delivery Characteristics," Eur. J. Pharm. Biopharm. 43 (1), 51–58 (1997).

5. W.E. Hennink and C.E. von Nustrum, "Novel Crosslinking Methods in Design of Hydrogels," Adv Drug Del. Rev, 54 (1), 13–36 (2002).

6. H. Park and K. Park, in Hydrogels and Biodegradable Polymers for Bioapplications, R.M. Ottenbrite, S.J. Huang and K. Park, Eds. (American Chemical Society, Washington, D.C., 1996), pp. 1–10.

7. N.A. Peppas, "Hydrogels and Drug Delivery," Curr. Opin. Coll. Int. Sci. 2, 531–537 (1997).


ADVERTISEMENT

RELATED CONTENT
Roche Recalls Viracept
Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
The Effect of Core and Coating Composition on Drug Release from Directly Compressed Time-Controlled Release Tablets
Near-Infrared Assay and Content Uniformity of Tablets
Maintain Your Moving Parts
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
75%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here